| (210) | Number of the EPO application | 16794479 |
| (220) | Filing date of the EPO application | 2016.10.28 |
| (80) | EPO patent specification publication (B) | EPB nr. 04/2021, 2021.01.27 |
| (110) | EPO patent number | 3368534 |
| (21) | Number of the application | e 2018 0863 |
| (71) | Name(s) of applicant(s), code of the country | NEUROCRINE BIOSCIENCES, INC., US; |
| (72) | Name(s) of inventor(s), code of the country | MCGEE Kevin, US;
ZOOK Scott, US;
CARR Andrew, GB;
BONNAUD Thierry, GB; |
| (73) | Name(s) of owner(s), code of the country | NEUROCRINE BIOSCIENCES INC., US; |
| (54) | Title of the invention | VALBENAZINE DITOSYLATE AND POLYMORPHS THEREOF |
| (13) | Kind-of-document code | A1 |
| (51) | International Patent Classification | C07D 471/04 (2006.01.01); A61K 31/4375 (2006.01.01); A61P 25/00 (2006.01.01) |
| (19) | Country | US |
| (41) | Date of publication of the application | 2018.10.31 |
| (30) | Priority | 201562249074 P, 2015.10.30, US |
| (86) | International application | PCT/US2016/059306, 2016.10.28 |
| (87) | International publication | WO 2017/075340, 2017.05.04 |